Nantahala Capital Management »

Dyne Therapeutics shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $8.5M 643k 13.30
2023-09-30 $6.1M 683k 8.96
2023-06-30 $6.7M 593k 11.25
2023-03-31 $2.1M 179k 11.52

More positions owned by Nantahala Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Meta Financial (CASH)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Costco Wholesale Corporation Put Option (COST)
Imax Corp Cad (IMAX)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)

View all positions for Nantahala Capital Management

Top funds holding Dyne Therapeutics

Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
Citadel Advisors
Vanguard Group
VR Adviser
Franklin Resources
Logos Global Management
Daniel D. Thurber
Artal Group
Frazier Life Sciences Management
Goldman Sachs Group
Ikarian Capital
Vivo Capital
Commodore Capital
Dimensional Fund Advisors

View all funds holding Dyne Therapeutics